BioAtla, Inc.
BCAB
$1.23
-$0.03-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 102.42% | 58.63% | 34.26% | -49.05% | 11.20% |
| Total Depreciation and Amortization | -100.00% | -34.43% | -91.67% | -75.44% | -49.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -76.16% | -747.23% | 8.19% | 55.47% | -32.93% |
| Change in Net Operating Assets | -145.32% | 426.83% | 119.50% | -19.85% | 431.21% |
| Cash from Operations | 97.03% | 67.66% | 52.84% | -92.54% | 26.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.62% | -- | -99.43% | -- | -80.74% |
| Repurchase of Common Stock | 80.00% | 51.72% | -- | 57.14% | 73.68% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 21.04% | -- | -- | -- |
| Cash from Financing | 105.56% | 127.85% | -27.92% | 57.14% | -116.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.05% | 69.09% | 83.91% | -92.13% | 25.37% |